Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?

Late relapse, defined as relapse arising after at least 5 years of remission, is rare and occurs in 1–3% of patients with acute myeloid leukemia (AML). The underlying mechanisms of late relapse remain poorly understood. We identified patients with AML who achieved remission with standard induction c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yilmaz, Musa, Wang, Feng, Loghavi, Sanam, Bueso-Ramos, Carlos, Gumbs, Curtis, Little, Latasha, Song, Xingzhi, Zhang, Jianhua, Kadia, Tapan, Borthakur, Gautam, Jabbour, Elias, Pemmaraju, Naveen, Short, Nicholas, Garcia-Manero, Guillermo, Estrov, Zeev, Kantarjian, Hagop, Futreal, Andrew, Takahashi, Koichi, Ravandi, Farhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335405/
https://www.ncbi.nlm.nih.gov/pubmed/30651532
http://dx.doi.org/10.1038/s41408-019-0170-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335405/
https://www.ncbi.nlm.nih.gov/pubmed/30651532
http://dx.doi.org/10.1038/s41408-019-0170-3

Ejemplares similares